This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
An international academic consortium has identified 13 biomarkers that significantly improve the ability to accurately predict cardiovasculardisease risk in people with type 2 diabetes.
Legume consumption has been linked to a reduced risk of type 2 diabetes (T2D) and cardiovasculardisease (CVD), while the potential association between plasma metabolites associated with legume consumption and.
Olive oil consumption has been inversely associated with the risk of type 2 diabetes (T2D) and cardiovasculardisease (CVD). However, the impact of olive oil consumption on plasma metabolites remains poorly un.
Babies born to pregnant women with obesity are more likely to develop heart problems and diabetes as adults due to fetal damage caused by the high-fat, high-energy diet of their mother.
People with type 2 diabetes had significantly fewer heart attacks, strokes, heart failures, and deaths from cardiovasculardisease when their blood pressure was lower than the current standard goal, a UT Southwestern Medical Center researcher and his colleagues found.
More than half of newly diagnosed cases of type 1 diabetes occur in adulthood. This review focuses on the prevention of cardiovasculardisease in patients with type 1 diabetes.
A new study has found that regular mobile phone use was positively associated with incident cardiovasculardisease risk, especially in current smokers and individuals with diabetes. In addition, this association was partly attributed to poor sleep, psychological distress, and neuroticism.
(MedPage Today) -- The FDA approved semaglutide (Ozempic) to reduce the risk of kidney disease worsening, kidney failure, and death due to cardiovasculardisease in adults with type 2 diabetes and chronic kidney disease (CKD), making it the only.
Diabetes affects millions of Americans. If managed well through proper diet and medication, those with diabetes can lead full and active lives. There are however some serious complications commonly associated with diabetes, like cardiovasculardisease, kidney disease, and PAD (Peripheral Artery Disease).
Diabetic kidney disease (DKD) is associated with a higher risk of cardiovasculardisease (CVD). Pentoxifylline (PTF), a nonselective phosphodiesterase inhibitor with anti-inflammatory, antiproliferative, and a.
February 1, 2024 — As cardiologists, heart disease patients and the organizations that serve them across the country embark on American Heart Month, DAIC has compiled a snapshot of significant cardiovasculardisease (CVD) and stroke statistics, along with a review of the atherosclerosis drug market. per 1,000* - 122.4
Higher levels of palmitoyl sphingomyelin (PSM, synonymous with sphingomyelin 16:0) are associated with an increased risk of cardiovasculardisease (CVD) in people with diabetes. Whether circulating PSM levels.
BackgroundCurrent evidence suggests that cardiovasculardisease (CVD) plays a role in the progression of chronic obstructive pulmonary disease (COPD). However, the relationship between CVD and the severity of COPD remains inadequately understood.
BackgroundType 2 diabetes (T2D) is a major risk factor for atherosclerotic cardiovasculardisease (ASCVD). Journal of the American Heart Association, Ahead of Print. A weighted polygenic risk score for T2D was calculated on the basis of 138 genetic variants associated with T2D.
In the US, over 45% of the population has either diabetes or pre-diabetes 1. The absolute majority of those with diabetes have type 2 diabetes, which is usually associated with excess visceral fat and poor cardiometabolic health. Because a diagnosis of diabetes is very likely to shorten your life. Pre-Diabetes.
Cardiovasculardisease (CVD) remains the leading cause of morbidity and mortality in patients with Type 1 Diabetes (T1D). Early markers of CVD include increased carotid intima-media thickness (CIMT) and pulse.
(MedPage Today) -- NEW ORLEANS -- Patients at a community health center who had type 2 diabetes and a high risk of atherosclerotic cardiovasculardisease (ASCVD) were under-prescribed guideline-recommended treatment with sodium-glucose cotransporter.
Andrew is a research scientist at Sansum Diabetes Research Institute, where he’s investigating metabolic therapies for health and disease. His mission is to optimize metabolic health and patient outcomes for people living with type 1 diabetes. Andrew is unique because he himself has type 1 diabetes.
A new study found balance and falling were linked to an increased risk of all-cause mortality, as well as cause-specific mortality from cardiovasculardisease and diabetes.
This new insight into the flow of fats through the body points to new therapeutic targets for mitigating diseases like ASCVD, non-alcoholic fatty liver disease, obesity, diabetes, peripheral neuropathy, and neurodegeneration.
The beneficial effects of fenofibrate on atherosclerotic cardiovasculardisease (ASCVD) outcomes in patients with diabetes and statin treatment are unclear. We investigated the effects of fenofibrate on all-ca.
years for women with type 2 diabetes. In modeling, the risk for any cardiovasculardisease event among women with a history of hypertensive disorders of pregnancy was generally 10% to 20% higher, with main models estimating hazard ratios to 1.20 (95% CI, 0.99–1.47) years for women with type 1 and 29.8
Evidence from the Look AHEAD study suggests achieving remission in type 2 diabetes is associated with risk reductions in chronic kidney disease and cardiovasculardisease.
million new cases of type 2 diabetes and 1.2 million new cases of cardiovasculardisease occur each year globally due to consumption of sugar-sweetened beverages. Friedman School of Nutrition Science and Policy at Tufts University, published in Nature Medicine, estimates that 2.2
The 2023 Almanac results derived from the Global Burden of Disease (GBD) and spanning 1990 to 2022, were recently published in the Journal of American College of Cardiology. The post Global Trends in CardiovascularDiseases: Insights from the 2023 Almanac appeared first on Cardiology Update. Original article: Mensah GA et al.
Objective Population-based national data on the trends in expenditures related to coexisting atherosclerotic cardiovasculardiseases (ASCVD) and diabetes is scarce. Individuals with diabetes had a 1.5-fold fold higher mean expenditure that those without diabetes. individuals aged ≥ 18 years.
Objective We aimed to summarize the association between gestational diabetes mellitus (GDM) and its intergenerational cardiovasculardiseases (CVDs) impacts in both mothers and offspring post-delivery in existing literature.
Findings from an observational analysis of ARISE-HF trial participants, newly-published in the Journal of the American College of Cardiology, JACC, shed light on the racial and ethnic disparities in diabetic cardiomyopathy (DbCM), which researchers note may have the potential to inform clinical practice, interventions, and policies.
Background Current clinical guidelines on cardiovasculardisease (CVD) do not specifically address the female population. The aim of this consensus is to know the opinion of a group of experts on the management of CVD in women.
Background Heart failure (HF) is a serious and common condition affecting millions of people worldwide, with obesity being a major cause of metabolic disorders such as diabetes and cardiovasculardisease. During the 4.22-year
Foot ulcers and/or infections are common long-term complications of diabetes and are associated with increased mortality, especially from cardiovasculardisease, though only a few studies have investigated the.
Among participants with type 2 diabetes and cardiovasculardisease, chronic kidney disease, or both, oral semaglutide (14 mg) was associated with a lower risk of cardiovascular events than placebo after 4 years of follow-up.
. -- A pharmacist-led intervention using notes in the electronic health record (EHR) proved effective for convincing primary care providers to switch veterans with diabetes and cardiovasculardisease (CVD) to.
Atherosclerotic cardiovasculardisease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3
Hypertension, cardiovasculardisease and kidney failure are associated with persistent hyperglycaemia and the subsequent development of nephropathy in people with diabetes. Diabetic nephropathy is associated w.
The reason excess weight is such big issues are the health consequences it confers with increased rates of diabetes, heart disease, osteoarthritis, obstructive sleep apnea, non-alcoholic fatty liver disease and others, just to name a few. Avoiding diabetes and its precursor states inclduing insulin resistance is key.
Cardiovasculardisease represents a significant risk factor for mortality in individuals with type 2 diabetes mellitus (T2DM). High-density lipoprotein (HDL) is believed to play a crucial role in maintaining c.
A systematic review of over 400 studies in type 2 diabetes reveals 13 biomarkers, including NT-proBNP and troponin-t, with potential to significantly enhance cardiovasculardisease risk prediction.
Eating patterns that align with the Mediterranean diet or the dietary approaches to stop hypertension (DASH) diet could help lower cardiovasculardisease risk in adults with type 1 diabetes, according to results from a six-year study.
With Medicare now covering semaglutide for people with obesity and cardiovasculardisease who don't have diabetes, a study looks at who that might include, depending on what cutoffs prescription plans apply.
Atherosclerosisa key driver of cardiovasculardisease (CVD)continues to be a significant global health issue. The Global Burden of Disease data (2023) highlights a grim reality: while high-income countries have seen some success in managing CVD, LMICs now account for most CVD-related deaths.
“Statins cause diabetes” This one is true. In truth, it is really those who are pre-diabetic who likely pull forward their diagnosis by about five days. But they do not magically take someone who is insulin-sensitive to full-blown type 2 diabetes overnight. 2 JACC: Cardiovascular Imaging May 2015, 8 (5) 579-596;
Driven by common pathophysiologic underpinnings (eg, inflammation and neurohormonal dysregulation), cardiovasculardisease, cognitive impairment, and frailty also share the following risk factors: hypertension, diabetes, obesity, sedentary behavior, and tobacco use.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content